XJPX
4526
Market cap550mUSD
Jun 24, Last price
3,050.00JPY
1D
1.50%
1Q
4.74%
Jan 2017
28.96%
Name
Riken Vitamin Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used in a wide array of products such as baked goods (bread, cake), desserts (whipped topping, ice cream), dairy items (coffee cream, margarine), and other food preparations like tofu, jam, marmalade, cocoa, chocolate, noodles, and mashed potatoes. A specific offering is distilled diglycerine ester, a compound resulting from the interaction of diglycerine with fatty acids. To prolong shelf life, Riken Vitamin supplies natural tocopherol, an antioxidant that prevents oxidation and maintains food freshness. Their product line further encompasses natural food colors and various flavorings suitable for seasoning seafood, poultry, and beef. The company also deals in wakame seaweed, frequently utilized in soups, salads, and instant noodle preparations, alongside integrated stabilizing and emulsifying solutions for frozen treats and dairy products. Additionally, they develop specialized bakery emulsifiers, bread improvers, and cake-enhancing agents. In the chemical realm, Riken Vitamin offers various improving agents, including glycerol, polyglycerol, sorbitan, propylene glycol, and other specialty esters, in addition to vitamins. Established in 1917, the company was initially known as Riken Vitamin Oil Co., Ltd. before rebranding as Riken Vitamin Co., Ltd. in 1980.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||